DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Talarozole is an investigational drug.
There have been 4 clinical trials for Talarozole. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2004.
The most common disease conditions in clinical trials are Psoriasis, Inflammation, and Dermatitis. The leading clinical trial sponsors are Stiefel, a GSK Company and [disabled in preview].
Recent Clinical Trials for Talarozole
|Study on Anti-inflammatory Effects of Topical R115866 Gel||Stiefel, a GSK Company||Phase 1|
|Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis||Stiefel, a GSK Company||Phase 2|
|An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne||Stiefel, a GSK Company||Phase 2|